Stacy R Lindborg
President, Chief Executive Officer and Board Director of IMUNON,
ArticleThe Bayesian Edge: how the new FDA guidance is enabling nimble, efficient clinical trials
Dr Stacy Lindborg, CEO of IMUNON, reflects on the FDA’s recent draft guidance that promotes the use of Bayesian modelling in clinical trials.